Dr. Krambeck investigates efficacy of Trilogy and ShockPulse-SE lithotripters

“You have tradeoffs with every device that you use,” says Amy E. Krambeck, MD.

In this episode, Urology Times® Managing Editor Ben Saylor spoke with Amy E. Krambeck, MD. She discusses the recent Journal of Endourology study, "Multi-institutional prospective randomized control trial of novel intracorporeal lithotripters: ShockPulse-SE vs Trilogy trial," for which she served as senior author. Krambeck is a professor of urology at Northwestern University Feinberg School of Medicine in Chicago, Illinois.

Related Videos
human kidney cross section showing kidney stones
cross section of human kidneys, one of which contains stones
blurred photo of a clinic hallway
blurred photo of clinic hallway
human kidney cross section
illustration of kidney cross section
medical depiction of human kidneys
Thomas Chi, MD, in an interview with Urology Times
© 2023 MJH Life Sciences

All rights reserved.